ABEO compared with ELUT: revenue, margins and what each company keeps, and the suppliers and customers both name

ABEOAbeona Therapeutics Inc.

Mkt capRevenueRevenue

ELUTElutia Inc.

Mkt capRevenueRevenue

Compare

ABEOAbeona Therapeutics Inc.

ELUTElutia Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABEO

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.7%▼−14.95%×0.50

May 13 '26±21.9%▲+0.53%×0.02

Q1 FY26±44.6%▼−3.84%×0.09

Q3 FY25±41.4%▲+18.47%×0.45

ELUT2 of 4 reports

Reportimpliedrealized× implied

Nov 6 '26—▲+11.52%—

Q2 FY26—▲+9.38%—

= impliedABEO realized, solidELUT realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedspan: ABEO 274d · ELUT 84dSource: market data

ABEOAbeona Therapeutics Inc.

4.14▲+5.75%· post 4.15

Mkt cap$238.5MRevenue$11MQ2 FY26

ELUTElutia Inc.

0.82▲+9.54%· post 0.82

ClosedNov 6 '26

Mkt cap$37.1MRevenue$2MQ2 FY26

Compare

ClosedNov 6 '26

ABEOAbeona Therapeutics Inc.

ELUTElutia Inc.

4.14▲+5.75%post 4.15

Price

0.82▲+9.54%post 0.82

$238.5M

Mkt cap

$37.1M

Q2 FY26$11M

Revenue

$2MQ2 FY26

ABEO4.14▲+5.75%vsELUT0.82▲+9.54%ClosedNov 6 '26